SCHEMBL6836702

SCHEMBL6836702

COc1ccc(C(=O)Nc2cccc(C(=O)O)c2)c2cc(C(=O)c3ccccc3)oc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 7/20 0.56
PDE4B Q07343 7/20 0.56
PDE4C Q08493 7/20 0.56
PDE4D Q08499 7/20 0.56
RAB9A P51151 7/20 0.53
NPC1 O15118 6/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
ALDH1A1 P00352 4/20 0.52
MAPT P10636 2/20 0.52
LMNA P02545 2/20 0.52
KCNK3 O14649 1/20 0.50
KCNK9 Q9NPC2 1/20 0.50
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
TP53 P04637 1/20 0.48
CDC25B P30305 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839420 0.89 RAB9A (0.55) PDE4APDE4BPDE4CPDE4DRAB9A
SCHEMBL6942657 0.84 PDE4A (0.71) PDE4APDE4BPDE4CPDE4DRAB9A
SCHEMBL6839328 0.83 SMN1; SMN2 (0.62) PDE4APDE4BPDE4CPDE4DRAB9A
SCHEMBL6837653 0.81 SMN1; SMN2 (0.60) PDE4APDE4BPDE4CPDE4DRAB9A
SCHEMBL6961385 0.79 PDE4D (0.86) PDE4APDE4BPDE4CPDE4D
SCHEMBL5723004 0.76 RAB9A (0.56) PDE4APDE4BPDE4CPDE4DRAB9A
SCHEMBL7821271 0.76 KCNK3 (0.82) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL6836500 0.74 ALDH1A1 (0.56) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL7051138 0.74 PDE4B (0.66) PDE4APDE4BPDE4CPDE4DRAB9A
SCHEMBL6837689 0.73 RAB9A (0.53) PDE4APDE4BPDE4CPDE4DRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 PDE4A 4879/4885PDE4B 4877/4885PDE4C 4882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.